Sequential
London, UK· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
An AI-powered gene therapy company developing targeted treatments for rare genetic diseases.
Rare DiseasesGenetic Disorders
Technology Platform
An AI and machine learning platform that analyzes genomic data to design and optimize gene therapy vectors for rare genetic conditions.
Opportunities
Leveraging AI to significantly reduce the time and cost of developing gene therapies for high-need, small patient populations.
Risk Factors
High technical risk in validating AI predictions biologically and clinically, coupled with the inherent challenges of gene therapy development and delivery.
Competitive Landscape
Competes with other AI-driven drug discovery startups and established gene therapy companies focusing on rare diseases.